Detalhe da pesquisa
1.
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Br J Haematol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593353
2.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
3.
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.
Int J Mol Sci
; 25(3)2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38338672
4.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci
; 25(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612799
5.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
6.
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia.
Curr Opin Hematol
; 29(2): 74-83, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35013048
7.
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Cancer Immunol Immunother
; 71(2): 251-265, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125345
8.
Volasertib as a monotherapy or in combination with azacitidine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia: summary of three phase I studies.
BMC Cancer
; 22(1): 569, 2022 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597904
9.
Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.
Future Oncol
; 18(24): 2639-2649, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35815644
10.
Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.
Int J Mol Sci
; 23(2)2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35055086
11.
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
Br J Cancer
; 125(2): 190-199, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824476
12.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 195(3): 388-398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590303
13.
Reliable isolation of human mesenchymal stromal cells from bone marrow biopsy specimens in patients after allogeneic hematopoietic cell transplantation.
Cytotherapy
; 22(1): 21-26, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31883948
14.
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.
Lancet Oncol
; 20(8): 1109-1123, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301962
15.
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(9): 1947-1951, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29793046
16.
Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML.
Blood
; 137(22): 3145-3148, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624009
17.
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug.
Blood
; 125(24): 3760-8, 2015 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25931586
18.
A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome.
Haematologica
; 107(11): 2742-2747, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734924
19.
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.
Stem Cells
; 34(2): 357-66, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26418955
20.
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
Br J Cancer
; 125(3): 465, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079081